I CFD sono strumenti complessi e presentano un alto rischio di perdere soldi rapidamente a causa della leva finanziaria. Il 74% dei conti di clienti al dettaglio perde denaro facendo trading con i CFD con questo fornitore. Devi verificare se comprendi pienamente come funzionano i CFD e se puoi permetterti di correre il rischio elevato di perdere i tuoi soldi.

Close

Fai trading su Amgen AMGN

Vendi
 Acquista

Grafico live di Amgen

5m 15m 30m 1h 4h 1d 1w

Fondamentali dello strumento

Weekly Search
Weekly
Daily
Data Chiudi Variazione variazione % Apertura Massimo Minimo

Le ultime notizie

Closing 2024
2024 Dec 26, 17:00

La prossima settimana:Chiusura del 2024 e primi dati economici del 2025

Forex Indici
UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

La prossima settimana: Ultima settimana del 2024 sui mercati finanziari

Forex Indici
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

La prossima settimana: I tassi di interesse USA e l’inflazione in Europa determineranno la direzione dei mercati

Forex Indici
Dyogenes Diniz 2024 Dec 05, 16:00

La prossima settimana: L’inflazione e i tassi di interesse condizioneranno i mercati questa settimana

Forex Indici
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

La prossima settimana: L’occupazione USA probabilmente guiderà il sentiment sul mercato questa settimana.

Forex Indici
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

La prossima settimana: I dati sull’inflazione nell’area euro probabilmente confermeranno il taglio di dicembre dei tassi della BCE

Forex Indici
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

L’importante rally dei titoli del tech in parte dipenderà dalle trimestrali di Nvidia che verranno pubblicate mercoledì.

Forex Indici
Markets.com Support Team 2024 Nov 07, 16:00

La prossima settimana: Trump trade, dati sull’inflazione e trimestrali di Disney

Forex Indici

Informazioni

Spread

1.98

Spread (%)

0.6765 %

Leva

1:5

Interesse overnight acquisto

-0.0597 %

Interesse overnight vendita

-0.0292 %

Valuta

USD

Orari di trading

Markets closed

Martedì

13:31 - 19:59

Lunedì

13:31-19:59

Mercoledì

13:31-19:59

Giovedi

13:31-19:59

Venerdì

13:31-19:59

Analisi e statistiche

Apertura

---

Chiusura precedente

---

Massimo/Minimo di 52 settimane

--- – ---

Capitalizzazione di mercato

149085257728

Azioni in circolazione

537204992

Data delle trimestrali (prossima)

1999-11-22

Rendimento da dividendo

2025-06-06

Data ex dividendo

2025-05-16

Tasso di dividendo annuale a termine

9.52

Rendimento del dividendo annuale a termine

0.0343

EPS

7.57

Scopri di più su questo strumento

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Strumenti correlati

Asset
Vendi
Acquista
variazione %

Fai trading ora

Fai trading ora

Fai trading ora

Fai trading ora
Strumenti correlati
Trustpilot
RequestMessages8TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version51.45msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
51.71ms
peak_memory
2MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktv4_ip_override=sv; XSRF-TOKEN=eyJpdiI6ImpnMkY4aytFOTA5MmtaZllGWmZ4MVE9PSIsInZhbHVlIjoiSk1SeUMrdVpVRVJOUTZYeXBjVXpYRG9hdjY0MzJtT21FWmt0NGFoWThjWTRvRWNPNU1BWEJOK3kwZzBNRjlFM3MrUHRzVkcyekU1Sk0rM2xWSDJSaVIzaFJLUG5ZTmNOTTI3SHlveXM1elUwdXIwUXNZNnJ4TDNYVlAvT1htbjUiLCJtYWMiOiJkMTAyNWQ0NDAzYjYwOTY4MDUwY2ViOGI5ZDlhOTJmNDRiOTlmNTRkODc5OWI3MWNlZDBiNDMzNDQzMDA2ZTQ4IiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6ImdCd2xaL3VHZnpzUjNodXNXT2dJY2c9PSIsInZhbHVlIjoiWTBuZWY2cFdsUDdXMUQweThQVzZhOFEwcy85d25JN04ra3FYa3dlNmVOV0swWlExQlNVRjBEUC9sR1A4TUZCV00weTlzTDRpK1R0YTBMd0dJOEQ3RWJDak4xODF4Kzg0RWxac2dXNzA0K05kQVZjeER6WFpuZ3BtdENYVW5EcnAiLCJtYWMiOiI5YzU1YWY5Yzg5YTM5ZDc0MmY1ZWQ4NTQzNWQ0NzA3M2Q1YzllNjA4Njc5N2Y0N2VhNzMyMzRkYTIzMmQwZTA1IiwidGFnIjoiIn0%3D; mktloc=eyJpdiI6IjdVdHZnak5CbWhPRHhqdVFlUmtBR0E9PSIsInZhbHVlIjoiTGNsRmZCck04OFBKdzBUaFZwTEc1dkc2eU50RkMxcVltVVBGNENvKzY5VXJ6Wkw1YkFVV1NLdnNSbEE0NFYvciIsIm1hYyI6IjkxOTIwZmQxOGQwZmI3NmYzMDU3MzNiMmYzOGQyMDJmOGZiYWFjMGU1YzVjZTc4NjM4MmEwM2E3ZmM2Yzc0ZDMiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fsv%252Finstrument%252Fexxon%252F; intent_instrument=exxon ◀mktv4_ip_override=sv; XSRF-TOKEN=eyJpdiI6ImpnMkY4aytFOTA5MmtaZllGWmZ4MVE9PSIsInZhbHVlIjoiSk1SeUMrdVpVRVJOUTZYeXBjVXpYRG9hdjY0MzJtT21FWmt0NGFoWThjWTRvRWNPNU1BWEJ ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:6 [▼
  "mktv4_ip_override" => null
  "XSRF-TOKEN" => "jAEMhuV8yZWHlsgQEHX4pgClpCN1FqBoCUvOIkhJ"
  "laravel_session" => "0vS7x9nzeMEH9r0hvBFX2cDMiRwutgGdGsAskMAh"
  "mktloc" => "us,us"
  "intent_group" => null
  "intent_instrument" => null
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Fri, 18 Apr 2025 21:45:23 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "jAEMhuV8yZWHlsgQEHX4pgClpCN1FqBoCUvOIkhJ"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/csrf"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (43.43ms)time
    • Application (8.01ms)time
    • Routing (488μs)
    • 1 x Booting (84.41%)
      43.43ms
      1 x Application (15.56%)
      8.01ms
      1 x Routing (0.95%)
      488μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              jAEMhuV8yZWHlsgQEHX4pgClpCN1FqBoCUvOIkhJ
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/csrf" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-18 21:45:26GET/it/instrument/amgen/867
              #22025-04-18 21:45:23GET/csrf (ajax)
              #32025-04-18 21:45:23GET/params (ajax)